According to experts in Parkinson\u2019s Disease management and treatment of its symptoms, to avoid these risks posed by Parkinson\u2019s oral medications, which also tend to cause on and off movement fluctuations,\u00a0a different kind of therapy is adopted.<\/p>\n
The goal of this therapy is to achieve a straight line, which means continuous drug delivery, and continuous dopaminergic stimulation (stimulation of the brain chemical known as Dopamine, which is responsible for movement). This is accomplished through the use of non-oral infusion therapies, which include:<\/p>\n
Duodopa \/ Levodopa, also known as L-dopa, is the first Parkinson\u2019s Disease modality of treatment, and its goal is of replenishing Dopamine levels. It comes in a gel form, which is given through an extension tube (PEGJ) which goes directly to the Jejunum, which is the second part of the small intestine. This means that this extension tube bypasses the stomach and the duodenum where a lot of gastric enzymes are secreted and hydrochloric acid release occurs, which can interfere with the Levodopa infusion therapy.<\/p>\n
The Levodopa infusion therapy provides\u00a0continuous Dopamine delivery to the brain and avoids any movement and non-movement fluctuations.<\/p>\n
The Parkinson’s infusion therapy programme at King’s Dubai is operated by the same multidisciplinary team of UK Parkinson’s Experts who operate the infusion programme in London.<\/p>\n
Video 1<\/strong> — Watch the recovery of\u00a0 Deeksha Raja, a patient from the UK who due to the COVID-19 pandemic was not able to return to the UK. Who blood pressure became dangerously low but now she enjoys a new lease of life thanks to Duodopa Infusion Therapy in Dubai<\/p>\n